You will read about risk factors that could increase your vulnerability to pneumonia, and what lifestyle and dietary habits can help reduce your risk
Sitting or lying down until the dizziness passes can help, but persistent dizziness should be evaluated by a healthcare provider
This pilot will measure the feasibility of a GLP-1 program for weight management that is flexible, accessible, and financially sustainable for our employees and the institution
"Making Wegovy available via these telehealth channels, with its clinically-tested weight loss in its premium pen delivery device, is an important step forward in allowing patients to receive care in the way they choose and helping them to achieve their weight loss goals with an authentic, FDA-approved medicine." First approved in 2021, Wegovy is the only FDA-approved semaglutide treatment for weight loss, and the medicine that changed how healthcare professionals (HCPs) treat patients with obesity as the first weekly GLP-1 for chronic weight management
Semaglutide 2.4 mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection